Review



ccl 231dq human gdna hepg2 atcc  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC ccl 231dq human gdna hepg2 atcc
    Ccl 231dq Human Gdna Hepg2 Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+gdna+sw48/SW48+Purified+Genomic+DNA%2C+Quantitative/pmc12570316__mmc3-549-233-237
    Average 99 stars, based on 9 article reviews
    ccl 231dq human gdna hepg2 atcc - by Bioz Stars, 2026-09
    99/100 stars

    Images

    Related Articles

    Biomarker Discovery:

    Article Title: Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment
    Article Snippet: Human gDNA: SW48 , ATCC , cat#: CCL-231DQ.

    Purification:

    Article Title: Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment
    Article Snippet: Human gDNA: SW48 , ATCC , cat#: CCL-231DQ.

    Adapter Ligation:

    Article Title: Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment
    Article Snippet: Human gDNA: SW48 , ATCC , cat#: CCL-231DQ.

    Isolation:

    Article Title: Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment
    Article Snippet: Human gDNA: SW48 , ATCC , cat#: CCL-231DQ.

    Magnetic Beads:

    Article Title: Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment
    Article Snippet: Human gDNA: SW48 , ATCC , cat#: CCL-231DQ.

    Modification:

    Article Title: Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment
    Article Snippet: Human gDNA: SW48 , ATCC , cat#: CCL-231DQ.

    Amplification:

    Article Title: Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment
    Article Snippet: Human gDNA: SW48 , ATCC , cat#: CCL-231DQ.

    Binding Assay:

    Article Title: Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment
    Article Snippet: Human gDNA: SW48 , ATCC , cat#: CCL-231DQ.

    Labeling:

    Article Title: Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment
    Article Snippet: Human gDNA: SW48 , ATCC , cat#: CCL-231DQ.

    Concentration Assay:

    Article Title: Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment
    Article Snippet: Human gDNA: SW48 , ATCC , cat#: CCL-231DQ.

    Incubation:

    Article Title: Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment
    Article Snippet: Human gDNA: SW48 , ATCC , cat#: CCL-231DQ.

    Methylation:

    Article Title: Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment
    Article Snippet: Human gDNA: SW48 , ATCC , cat#: CCL-231DQ.



    Similar Products

    99
    ATCC ccl 231dq human gdna hepg2 atcc
    Ccl 231dq Human Gdna Hepg2 Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+gdna+sw48/SW48+Purified+Genomic+DNA%2C+Quantitative/pmc12570316__mmc3-549-233-237
    Average 99 stars, based on 1 article reviews
    ccl 231dq human gdna hepg2 atcc - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    96
    ATCC human gdna sw48
    Schematic of the Active-Seq workflow and initial method validation using synthetic oligonucleotides (A) Schematic showing the single-tube, Active-Seq workflow. Purified DNA (cfDNA or fragmented <t>gDNA)</t> is tagged using a CpG-targeting methyltransferase (M.MpeI) and a synthetic cofactor analog. The enzyme catalyzes DNA alkylation with azide-terminated tags exclusively at unmodified CpG sites. Tagged DNA molecules are subsequently subject to standard library end repair and adapter ligation, followed by affinity tagging and isolation using streptavidin-coated magnetic beads. Tagged (unmodified CpG sites, Active-Seq) and untagged (5mCpG and other modified CpG sites and CpG-free fragments, unbound fraction) DNA can be separately amplified and sequenced. (B) Plot showing the efficiency for DNA binding and release (recovery) of tagged and affinity-labeled DNA, using 10 ng target DNA input, as a function of target DNA CpG site density. Binding efficiency is calculated based on the assumption that any reduction in DNA concentration after DNA incubation with beads is as a result of DNA binding to the beads. (C) Plot showing the efficiency for binding and release (recovery) of tagged and affinity-labeled DNA for a decreasing amount of input target DNA against a background of 24 ng of non-target DNA (containing no CpG sites). Note that the recovered DNA concentration was determined by qPCR, and reported recoveries are measured against DNA we expect to be bound to the beads (input DNA quantified via Qubit). (D) Plot showing number of reads of spiked-in DNA oligos (5, 25, and 50 pg in total) in the enriched (unmethylated) fraction with four unmethylated CpG sites (4 uMe CpG), four methylated CpG sites (4 Me CpG), and no target CpG sites (0 CpG) from a typical Active-Seq experiment. (E) Plot showing number of reads of spiked-in DNA oligos (5, 25, and 50 pg in total) in the unbound fraction with four unmethylated CpG sites (4 uMe CpG), four methylated CpG sites (4 Me CpG), and no target CpG sites (0 CpG) from a typical Active-Seq experiment. Data in bar-plots are presented as mean ± SD of three independent replicates. Two-way ANOVA test: ∗ p < 0.05, ∗∗ p < 0.01 , ∗∗∗ p < 0.001 and ∗∗∗∗ p < 0.0001.
    Human Gdna Sw48, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+gdna+sw48/SW48/pmc12570316-38-0-4
    Average 96 stars, based on 1 article reviews
    human gdna sw48 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    93
    ATCC htb 38d human gdna sw48 atcc
    Schematic of the Active-Seq workflow and initial method validation using synthetic oligonucleotides (A) Schematic showing the single-tube, Active-Seq workflow. Purified DNA (cfDNA or fragmented <t>gDNA)</t> is tagged using a CpG-targeting methyltransferase (M.MpeI) and a synthetic cofactor analog. The enzyme catalyzes DNA alkylation with azide-terminated tags exclusively at unmodified CpG sites. Tagged DNA molecules are subsequently subject to standard library end repair and adapter ligation, followed by affinity tagging and isolation using streptavidin-coated magnetic beads. Tagged (unmodified CpG sites, Active-Seq) and untagged (5mCpG and other modified CpG sites and CpG-free fragments, unbound fraction) DNA can be separately amplified and sequenced. (B) Plot showing the efficiency for DNA binding and release (recovery) of tagged and affinity-labeled DNA, using 10 ng target DNA input, as a function of target DNA CpG site density. Binding efficiency is calculated based on the assumption that any reduction in DNA concentration after DNA incubation with beads is as a result of DNA binding to the beads. (C) Plot showing the efficiency for binding and release (recovery) of tagged and affinity-labeled DNA for a decreasing amount of input target DNA against a background of 24 ng of non-target DNA (containing no CpG sites). Note that the recovered DNA concentration was determined by qPCR, and reported recoveries are measured against DNA we expect to be bound to the beads (input DNA quantified via Qubit). (D) Plot showing number of reads of spiked-in DNA oligos (5, 25, and 50 pg in total) in the enriched (unmethylated) fraction with four unmethylated CpG sites (4 uMe CpG), four methylated CpG sites (4 Me CpG), and no target CpG sites (0 CpG) from a typical Active-Seq experiment. (E) Plot showing number of reads of spiked-in DNA oligos (5, 25, and 50 pg in total) in the unbound fraction with four unmethylated CpG sites (4 uMe CpG), four methylated CpG sites (4 Me CpG), and no target CpG sites (0 CpG) from a typical Active-Seq experiment. Data in bar-plots are presented as mean ± SD of three independent replicates. Two-way ANOVA test: ∗ p < 0.05, ∗∗ p < 0.01 , ∗∗∗ p < 0.001 and ∗∗∗∗ p < 0.0001.
    Htb 38d Human Gdna Sw48 Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+gdna+sw48/Human+genomic+DNA/pmc12570316__mmc3-549-227-231
    Average 93 stars, based on 1 article reviews
    htb 38d human gdna sw48 atcc - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    Schematic of the Active-Seq workflow and initial method validation using synthetic oligonucleotides (A) Schematic showing the single-tube, Active-Seq workflow. Purified DNA (cfDNA or fragmented gDNA) is tagged using a CpG-targeting methyltransferase (M.MpeI) and a synthetic cofactor analog. The enzyme catalyzes DNA alkylation with azide-terminated tags exclusively at unmodified CpG sites. Tagged DNA molecules are subsequently subject to standard library end repair and adapter ligation, followed by affinity tagging and isolation using streptavidin-coated magnetic beads. Tagged (unmodified CpG sites, Active-Seq) and untagged (5mCpG and other modified CpG sites and CpG-free fragments, unbound fraction) DNA can be separately amplified and sequenced. (B) Plot showing the efficiency for DNA binding and release (recovery) of tagged and affinity-labeled DNA, using 10 ng target DNA input, as a function of target DNA CpG site density. Binding efficiency is calculated based on the assumption that any reduction in DNA concentration after DNA incubation with beads is as a result of DNA binding to the beads. (C) Plot showing the efficiency for binding and release (recovery) of tagged and affinity-labeled DNA for a decreasing amount of input target DNA against a background of 24 ng of non-target DNA (containing no CpG sites). Note that the recovered DNA concentration was determined by qPCR, and reported recoveries are measured against DNA we expect to be bound to the beads (input DNA quantified via Qubit). (D) Plot showing number of reads of spiked-in DNA oligos (5, 25, and 50 pg in total) in the enriched (unmethylated) fraction with four unmethylated CpG sites (4 uMe CpG), four methylated CpG sites (4 Me CpG), and no target CpG sites (0 CpG) from a typical Active-Seq experiment. (E) Plot showing number of reads of spiked-in DNA oligos (5, 25, and 50 pg in total) in the unbound fraction with four unmethylated CpG sites (4 uMe CpG), four methylated CpG sites (4 Me CpG), and no target CpG sites (0 CpG) from a typical Active-Seq experiment. Data in bar-plots are presented as mean ± SD of three independent replicates. Two-way ANOVA test: ∗ p < 0.05, ∗∗ p < 0.01 , ∗∗∗ p < 0.001 and ∗∗∗∗ p < 0.0001.

    Journal: Cell Reports Methods

    Article Title: Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment

    doi: 10.1016/j.crmeth.2025.101187

    Figure Lengend Snippet: Schematic of the Active-Seq workflow and initial method validation using synthetic oligonucleotides (A) Schematic showing the single-tube, Active-Seq workflow. Purified DNA (cfDNA or fragmented gDNA) is tagged using a CpG-targeting methyltransferase (M.MpeI) and a synthetic cofactor analog. The enzyme catalyzes DNA alkylation with azide-terminated tags exclusively at unmodified CpG sites. Tagged DNA molecules are subsequently subject to standard library end repair and adapter ligation, followed by affinity tagging and isolation using streptavidin-coated magnetic beads. Tagged (unmodified CpG sites, Active-Seq) and untagged (5mCpG and other modified CpG sites and CpG-free fragments, unbound fraction) DNA can be separately amplified and sequenced. (B) Plot showing the efficiency for DNA binding and release (recovery) of tagged and affinity-labeled DNA, using 10 ng target DNA input, as a function of target DNA CpG site density. Binding efficiency is calculated based on the assumption that any reduction in DNA concentration after DNA incubation with beads is as a result of DNA binding to the beads. (C) Plot showing the efficiency for binding and release (recovery) of tagged and affinity-labeled DNA for a decreasing amount of input target DNA against a background of 24 ng of non-target DNA (containing no CpG sites). Note that the recovered DNA concentration was determined by qPCR, and reported recoveries are measured against DNA we expect to be bound to the beads (input DNA quantified via Qubit). (D) Plot showing number of reads of spiked-in DNA oligos (5, 25, and 50 pg in total) in the enriched (unmethylated) fraction with four unmethylated CpG sites (4 uMe CpG), four methylated CpG sites (4 Me CpG), and no target CpG sites (0 CpG) from a typical Active-Seq experiment. (E) Plot showing number of reads of spiked-in DNA oligos (5, 25, and 50 pg in total) in the unbound fraction with four unmethylated CpG sites (4 uMe CpG), four methylated CpG sites (4 Me CpG), and no target CpG sites (0 CpG) from a typical Active-Seq experiment. Data in bar-plots are presented as mean ± SD of three independent replicates. Two-way ANOVA test: ∗ p < 0.05, ∗∗ p < 0.01 , ∗∗∗ p < 0.001 and ∗∗∗∗ p < 0.0001.

    Article Snippet: Human gDNA: SW48 , ATCC , cat#: CCL-231DQ.

    Techniques: Biomarker Discovery, Purification, Adapter Ligation, Isolation, Magnetic Beads, Modification, Amplification, Binding Assay, Labeling, Concentration Assay, Incubation, Methylation